Michelle Dipp

Michelle is the Director of Corporate Development for Sirtris Pharmaceuticals, a Glaxo Smith Kline Company. Prior to joining Sirtris, Michelle worked with Direct Investments, the healthcare venture capital arm of The Wellcome Trust, London. She previously did Post-Doctoral Research in the Department of Pharmacology and the Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford. She has published several papers in peer-reviewed journals in the pulmonary field. Michelle holds an M.D. and a Ph.D. in Pulmonary Physiology from the University of Oxford.